Profound Medical to present first CAPTAIN trial outcomes at EAU 2026, host investor call March 13

Profound Medical Corp.

First CAPTAIN trial outcomes (TULSA vs radical prostatectomy) presented at EAU 2026 on March 13 at 9:40 a.m. EDT.
Investor webinar at 11:30 a.m. EDT on March 13 with Dr. Laurence Klotz reviewing data and commercial implications.
Management to participate in Roth Conference March 22-24 in Dana Point, CA; one-on-one meetings.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.